Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  2, 1116 - 1121 (1996)
doi:10.1038/nm1096-1116

Oral immunization with an anti−idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection

Judith A. Whittum-Hudson1, 4, Ling-Ling An2, 4, W. Mark Saltzman3, 5, Robert A. Prendergast1 & A. Bruce Macdonald2

  1The Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-9142

  2Department of Microbiology, University of Massachusetts, North Pleasant Street, Amherst, Massachusetts 01003, USA

  3Department of Chemical Engineering, Johns Hopkins University, 3400 North Charles Street, Baltimore, Maryland 21218, USA

  4J.A.W.-H. L.-L.A. present address: Department of Neuropharmacology, Scripps Research Institute, 10666 North Toney Pines Road, La folia, California 92034, USA

  5W.M.S. present address: School of Chemical Engineering, Cornell University, Campus Road, Ithaca, New York 14853, USA

Chlamydia trachomatis is the leading cause worldwide of preventable infectious blindness (trachoma) and sexually transmitted disease, including nongonoccocal urethritis and pelvic inflammatory disease. To date, no effective vaccine against C. trachomatis infection has been identified. A monoclonal anti−idiotypic antibody (anti−Id) to the chlamydial exoglycolipid antigen (GLXA) was tested in a murine model of ocular chlamydial infection for its ability to induce systemic immunity, which reduces microbiologic and clinical disease. The anti−Id to GLXA, delivered either systemically in soluble form or orally after encapsulation in poly(lactide) microspheres, induced significant protective immunity against ocular challenge of mice with a human biovar of C. trachomatis. Protection was associated with induction of anti−GLXA antibody and anti−chlamydial neutralizing antibody.

REFERENCES
  1. Schachter, J. & Dawson, C.R. The epidemiology of trachoma predicts more blindness in the future. Scand. J. Infect. Dis. 69 (Suppl.), 55−62 (1990). | ChemPort |
  2. Piot, P. Van den Hoek, A.R., Van Damme, L. & Laga, M. Epidemiology and control of genital chlamydial infections. in Chlamydial Infections, (eds. Orfila, J. et al) 7−15 (Societa Editrice Esculapio, Bologna, 1994).
  3. Taylor, H.R. et al. An animal model of trachoma. II. The importance of repeated reinfection. Invest. Ophthalmol. Vis. ScL 23, 507−515 (1982). | ChemPort |
  4. Weström, L. & Wölner-Hanssen, P. Pathogenesis of pelvic inflammatory disease. Genitourin. Med. 69, 9−17 (1993). | PubMed  | ISI |
  5. Stephens, R.S., Wagar, E. & Schoolnik, G. High resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis. J. Exp. Med. 167, 817−831 (1988). | PubMed  | ISI | ChemPort |
  6. Newhall, W.J.V., Batteiger, B. & Jones, R.B. Analysis of human serological responses to proteins of Chlamydia trachomatis. Infect. Immun. 38, 1181−1189 (1982). | PubMed  | ISI | ChemPort |
  7. Wagar, E.A., Schachter, J., Bavoil, P. & Stephens, R.S. Differential human sero-logic response to two 60,000 molecular weight Chlamydia trachomatis antigens. J. Infect. Dis. 162, 922−927 (1990). | PubMed  | ISI | ChemPort |
  8. Ting, L., Hsia, R., Haidaris, C.G. & Bavoil, P.M. Interaction of outer envelope proteins of Chlamydia psittaci GPIC with the HeLa cell surface. Infect. Immun. 63, 3600−3608 (1995). | PubMed  | ISI | ChemPort |
  9. Brunham, R.C. et al. Post-abortal Chlamydia trachomatis salpingitis: Correlating risk with antigen-specific responses and with neutralization. J. Infect. Dis. 155, 749−755 (1987). | PubMed  | ISI | ChemPort |
  10. Campos, M. et al. An extract of the major outer membrane protein of Chlamydia trachomatis as a trachoma vaccine candidate. Invest. Ophthalmol. Vis. Sci 36, 1477−1491 (1995). | PubMed  | ISI | ChemPort |
  11. Batteiger, B.E., Rank, R.G., Bavoil, P.M. & Soderberg, L.S.F. Partial protection against genital reinfection by immunization of guinea pigs with isolated outer membrane proteins of the chlamydial agent guinea pig inclusion conjunctivitis. J. Gen. Microbiol 139, 2965−2972 (1993). | PubMed  | ISI | ChemPort |
  12. An, L.L. Production and characterization of anti-idiotypic antibodies, biological mimicry of a glycolipid exoantigen of Chlamydia trachomatis in vivo. Ph.D. dissertation, Univ. Massachusetts, Amherst (1993).
  13. Stuart, E.S. & MacDonald, A.B. Identification of two fatty acids in a group determinant of Chlamydia trachomatis. Curr. Microbiol. 11, 123−128 (1984). | ISI | ChemPort |
  14. Stuart, E.S., Wyrick, P.B., Choong, J., Stoler, S.B. & MacDonald, A.B. Examination of chlamydial glycolipid with monoclonal antibodies: Cellular distribution and epitope binding. Immunology 74, 740−747 (1991). | PubMed  | ISI | ChemPort |
  15. Stuart, E.S., Tirrell, S.M. & MacDonald, A.B. Characterization of an antigen secreted by chlamydial infected cell culture. Immunology 61, 527−533 (1987). | PubMed  | ISI | ChemPort |
  16. Wyrick, P. et al. Chlamydia trachomatis antigens on the surface of human endometrial cells. Immunol. Infect. Dis. 4, 131−141 (1994).
  17. Stuart, E.S., Troidle, K.M. & MacDonald, A.B. Chlamydial glycolipid antigen: Extracellular accumulation, biological activity, and antibody recognition. Curr. Microbiol. 28, 85−90 (1994). | ISI | ChemPort |
  18. Stuart, E.S. & MacDonald, A.B. Some characteristics of a secreted chlamydial antigen recognized by IgG from Chlamydia trachomatis patient sera. Immunology 68, 469−473 (1989). | PubMed  | ISI | ChemPort |
  19. Schachter, J. Overview of Chlamydia trachomatis infection and the requirements for a vaccine. Rev. Infect. Dis. 7, 713−716 (1985). | PubMed  | ISI | ChemPort |
  20. Michalek, S.M. et al. The IgA response: Inductive aspects, regulatory cells, and effector functions. Ann. N.Y. Acad. Sci. 409, 48−71 (1983). | PubMed  | ChemPort |
  21. Pal, S., Pu, Z., Huneke, R.B., Taylor, H.R. & Whittum-Hudson, J.A. Chlamydia-specific lymphocytes in conjunctiva during ocular infection: Limiting dilution analysis. Reg. Immunol 3, 171−176 (1990). | PubMed  |
  22. Rank, R.G. & Sanders, M.M. Pathogenesis of endometritis and salpingitis in a guinea pig model of chlamydial genital infection. Am. J. Pathol. 140, 927−936 (1992). | PubMed  | ISI | ChemPort |
  23. Reacher, M.H., Péer, J., Rapoza, P.A., Whittum-Hudson, J.A. & Taylor, H.R. T-cells and trachoma: Their role in cicatricial disease. Ophthalmology 98, 334−341 (1991). | PubMed  | ISI | ChemPort |
  24. Cain, T.K. & Rank, R.G. Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect. Immun. 63, 516−521 (1995). | PubMed  |
  25. Su, H. & Caldwell, H.D. CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect. Immun. 63, 3302−3308 (1995). | PubMed  | ISI | ChemPort |
  26. Rolf, J.M., Gaudin, H.M., Tirrell, S.M., MacDonald, A.B. & Eidels, L. Anti-idiotypic antibodies that protect cells against the action of diphtheria toxin. Proc. Natl. Acad. Sci. USA 86, 2036−2039 (1989). | PubMed  | ChemPort |
  27. Nisonoff, A. & La Moyi, E. Implications of the presence of an internal image of the antigen in anti-Id antibodies: Possible application to vaccine production. Clin. Immunol. Immunopathol. 21, 397−403 (1981). | Article | PubMed  | ISI | ChemPort |
  28. Stein, K.E. Network regulation of the immune response to bacterial polysaccharide antigens. Curr. Top. Microbiol Immunol 119, 57−74 (1985). | PubMed  | ISI | ChemPort |
  29. Kennedy, R.C., Dreesman, G.R. & Kohler, H. Vaccines utilizing internal image anti-idiotypic antibodies that mimic antigens of infectious organisms. BioTechniques 3, 404−409 (1985).
  30. Su, S., Ward, M.M., Apicella, M.A. & Ward, R.E. A nontoxic, idiotope vaccine against gram-negative bacterial infections. J. Immunol 148, 234−238 (1992). | PubMed  | ISI | ChemPort |
  31. Hawkins, R.E., Winter, G., Hamblin, T.J., Stevenson, F.K. & Russell, S.J. A genetic approach to idiotypic vaccination. J. Immunother. 14, 273−278 (1993). | PubMed  | ISI | ChemPort |
  32. Eldridge, J., Hammond, C., Meulbroek, J., Gilley, R. & Tice, T. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J. Controlled Release 11, 205−214 (1990). | Article | ISI | ChemPort |
  33. Challacombe, S., Rahman, D., Jeffery, H., Davis, S. & ÓHagan, D. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology 76, 164−168 (1992). | PubMed  | ISI | ChemPort |
  34. Marx, P.A. et al. Protection against vaginal SIV transmission with microencap-sulated vaccine. Science 260, 1323−1327 (1993). | PubMed  | ISI | ChemPort |
  35. Whittum-Hudson, J.A., ÓBrien, T.P. & Prendergast, A. Murine model of ocular infection by a human biovar of Chlamydia trachomatis. Invest. Ophthalmol Vis. Sci. 36, 1976−1987 (1995). | PubMed  | ChemPort |
  36. Blanchard, T.G., An, L., Troidle, K.M., Tirrell, S.M. & MacDonald, A.B. Internal image of exoglycolipid genus-specific antigen produced by anti-idiotype. in Chlamydial Infections (eds. Bowie, W.R. et al) 205−208 (Cambridge Univ. Press, Cambridge, 1990).
  37. Troidle, K.M. Characterization of a genus-specific chlamydial antigen. Ph.D. thesis, Univ. Massachusetts, Amherst. (University Microfilms, Ann Arbor, Michigan, 1992).
  38. Scieux, C. et al. Evaluation of a new chemiluminometric immunoassay, Magic Lite Chlamydia, for detecting Chlamydia trachomatis antigen from urogenital specimens. Sex. Transm. Dis. 19, 161−164 (1992). | PubMed  | ISI | ChemPort |
  39. Murdin, A.D., Su, H., Klein, M.H. & Caldwell, H.D. Poliovirus hybrids expressing neutralization epitopes from variable domains I and IV of the major outer membrane protein of Chlamydia trachomatis elicit broadly cross-reactive C. tra-dwmfltfs-neutralizing antibodies. Infect. Immun. 63, 1116−1121 (1995). | PubMed  | ISI | ChemPort |
  40. Su, H., Parnell, M. & Caldwell, H.D. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: Serum neutralizing antibodies do not protect against chlamydial genital tract infection. Vaccine 13, 1023−1032 (1995). | Article | PubMed  | ISI | ChemPort |
  41. Brossay, L. et al. Mimicry of a neutralizing epitope of the major outer membrane protein of Chlamydia trachomatis by anti-idiotypic antibodies. Infect. Immun. 62, 341−347 (1994). | PubMed  | ISI | ChemPort |
  42. Jerne, N.K. Towards a network theory of the immune system. Ann. Immunol (Inst Pasteur) 125C, 373−389 (1974). | ChemPort |
  43. Fields, B.A., Goldbaum, F.A., Ysern, X., Poljak, R.J. & Mariuzza, R.A. Molecular basis of antigen mimicry by an anti-idiotope. Nature 374, 739−742 (1995). | Article | PubMed  | ISI | ChemPort |
  44. Westerink, M.A. & Apicella, M.A. Anti-idiotypic antibodies as vaccines against carbohydrate antigens [Review]. Springer Semin. Immunopathol 15, 227−234 (1993). | PubMed  | ISI | ChemPort |
  45. Rees, A.D.M. et al. T cell activation by anti-idiotypic antibody: Mechanism of interaction with antigen-reactive T cell. Eur. J. Immunol. 17, 197−201 (1987). | PubMed  | ISI | ChemPort |
  46. Taylor, H.R., Johnson, S.L., Schachter, J., Caldwell, H.D. & Prendergast, R.A. Pathogenesis of trachoma: The stimulus for inflammation. J. Immunol. 138, 3023−3027 (1987). | PubMed  | ISI | ChemPort |
  47. Kiyono, H. & McGhee, J.R. T helper cells for mucosal immune responses. in Handbook of Mucosal Immunology. (ed. Ogra, P.L.) 263−274 (Academic Press, New York, 1994).
  48. Igietseme, J.U. et al. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. Reg. Immunol. 5, 317−324 (1993). | PubMed  | ChemPort |
  49. Magee, D.M. et al. Role of CD8 T cells in primary chlamydia infection. Infect. Immun. 63, 516−521 (1995). | PubMed  | ISI | ChemPort |
  50. Harlow, E. & Lane, D. The Antibodies, 139−243 (Cold Spring Harbor Press, Cold Spring Harbor, New York, 1994).
  51. Cohen, S., Yoshioka, T., Lucarelli, M., Hwang, L. & Langer, R. Controlled delivery systems for proteins based on poly (lactic/glycolic acid) microspheres. Pharm. Res. 8, 713−720 (1991). | Article | PubMed  | ISI | ChemPort |
  52. Salehi-Had, S. & Saltzman, W.M. Controlled intracranial delivery of antibodies in the rat. in Protein Formulations and Delivery. (eds. Cleland, J. & Langer, R.) 278−298 [(ACS (Am. Chem. Soc.) Symp. Series, Washington, DC, 1994)]. | ChemPort |
  53. Taylor, H.R., Agarwala, N. & Johnson, S.L. Detection of experimental Chlamydia trachomatis eye infection in conjunctival smears and in tissue culture by use of fluorescein-conjugated monoclonal antibody. J. Clin. Microbiol 20, 391−395 (1984). | PubMed  | ISI | ChemPort |
  54. Byrne, G.I. et al. Workshop on in vitro neutralization of Chlamydia trachomatis: Summary of proceedings. J. Infect. Dis. 168, 415−420 (1993). | PubMed  | ISI | ChemPort |
 Top
 Top
Abstract
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1996 Nature Publishing Group | Privacy policy